PTAB Denies Joinder of IPR Petitioner That Won't Take "Silent Understudy" Role

PTAB Denies Joinder of IPR Petitioner That Won't Take "Silent Understudy" Role


In orders entered July 10 and 12, 2017, the PTAB instituted further inter partes review of six Allergan Inc. patents relating to cyclosporine compositions. Each of U.S. Patent Nos.



from Biotech News